← Evidence map

ArticlePloS one2017

Correction: Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma.

PLOS ONE StaffPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Correction: Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma. | OpenQuestion